About My Health Careers Internship MedBlogs Contact us
Medindia
LOGIN REGISTER
Advertisement

New Guidelines on Polymyxins, Life-saving Antibiotic Issued

by Colleen Fleiss on March 10, 2019 at 3:18 PM
Font : A-A+

New Guidelines on Polymyxins, Life-saving Antibiotic Issued

New guidelines on the use of polymyxins, a class of antibiotics employed as a last resort to treat deadly, drug-resistant bacteria have been formed by an international panel of the foremost researchers on infectious disease and antimicrobials.

The guidelines, published last month in Pharmacotherapy, set new standards for the clinical use of polymyxins, including on maximum dosage, treatment strategies and best practice for use in combination with other antibiotics.

Advertisement


The recommendations have been endorsed worldwide by six international societies and organizations across the globe: American College of Clinical Pharmacy, European Society of Clinical Microbiology and Infectious Diseases, Infectious Diseases Society of America, International Society for Anti-infective Pharmacology, Society of Critical Care Medicine and Society of Infectious Diseases Pharmacists.

The expert panel was co-led by Brian Tsuji, PharmD, professor of pharmacy practice in the University at Buffalo School of Pharmacy and Pharmaceutical Sciences; Jason Pogue, PharmD, clinical pharmacist specialist at the Detroit Medical Center; and Keith Kaye, MD, professor of infectious disease and internal medicine in the University of Michigan Medical School.
Advertisement

"There is considerable confusion on how to optimally use the polymyxin antibiotics," said Tsuji. First introduced in the 1950s, polymyxins are an older generation of antibiotics that fell out of favor due to their toxicity to the kidneys. However, the drug was recently resurrected by researchers and clinicians to aid in the fight against increasingly antibiotic-resistant bacteria, more commonly known as superbugs.

But while polymyxins have made a comeback, the clinical standards that guide its use are outdated. Variations in conventions used to describe doses, differing formulations and dated product information have led to confusion on how to best use and dose the drug. The recent publication provides clinicians with 34 recommendations for using polymyxin B and colistin - also known as polymyxin E. Highlights from the paper include:

The maximum tolerable dosage of polymyxin B and colistin is set at two milligrams per liter. Polymyxin B is preferred for routine systemic use against invasive infections, while colistin is preferred for the treatment of lower urinary tract infections and for delivery to the heart, brain and spinal canal.

Patients receiving polymyxins should avoid agents that are toxic to the kidneys, such as nonsteroidal anti-inflammatory drugs (common pain relievers that include aspirin and ibuprofen) and angiotensin-converting-enzyme inhibitors (drugs used primarily to treat hypertension and congestive heart failure).

To reduce confusion over labeling conventions used in different parts of the world, hospitals and prescription orders should specify doses of colistin in either international units (IU) or milligrams of colistin base activity (CBA).

In the treatment of the superbugs carbapenem-resistant P. aeruginosa (CRPA) and carbapenem-resistant Enterobacteriaceae (CRE), polymyxins should be used in combination with one or more antibiotics, ideally a drug the bacteria is susceptible to.

In the treatment of the superbug carbapenem-resistant A. baumannii (CRAB), polymyxins should only be used in combination with an antibiotic that the bacteria is susceptible to. If no such drug is available, the polymyxin should be delivered alone.

The panel recommended several areas of research needed in the future, including studies that compare the effectiveness and toxicity of polymyxin B and colistin, investigate biomarkers that rapidly respond to kidney damage to better detect the adverse effects of polymyxins, weigh the risks and benefits of curing infection at the expense of kidney damage, and measure the effectiveness of various combination therapies.

Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Category
What's New on Medindia
Emotional Healing
Psychosis Risk Related to Cat Parasite
Sedentary Behavior Precipitates Night-Time Hot Flashes
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
MRSA - The Super Bug Drug Resistance - Antibiotic Resistance Antibiotics Eye Infections Natural Antibiotics to Fight Bacterial Infections Vancomycin-Resistant Enterococci (VRE) Boils - Treatment by Drugs Multiple Drug Allergy Syndrome Interaction of Antibiotics with Dairy Products 

Recommended Reading
Antibiotics
Antibiotics are among the most used and abused medications. This article explains some general ......
Interaction of Antibiotics with Dairy Products
Antibiotics like tetracyclines and fluoroquinolones used in the treatment of bacterial infections .....
Natural Antibiotics to Fight Bacterial Infections
Fighting infections the natural way and preventing them is always more effective than consuming ......
Quiz on Antibiotics
Your doctor may suggest antibiotics at the first sight of an infection, but how much do you ......
Boils - Treatment by Drugs
Diabetes patients have reduced immunity, which makes them more susceptible to skin infections like b...
Drug Resistance - Antibiotic Resistance
Drug resistance is often a problem in malaria, tuberculosis, HIV, sexually transmitted diseases and ...
Eye Infections
Eye infection is a common problem that often causes pain and discomfort to the eyes. Common symptoms...
MRSA - The Super Bug
MRSA infection is the most dreaded hospital or community acquired infection that can become ......
Multiple Drug Allergy Syndrome
Multiple drug allergy syndrome or multiple drug hypersensitivity syndrome is a condition that causes...
Vancomycin-Resistant Enterococci (VRE)
Enterococci are a group of gram-negative bacteria that mostly inhabit the human gut. At present ther...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use